| Time | A | B | C | D | |
|---|---|---|---|---|---|
| 08:00-09:00 | Poster & Exhibition |
||||
| Opening Ceremony | |||||
| 09:00-10:30 | ASCO/KSMO JS Accelerating precision medicine in real-world and utilizing real-world evidence |
Scientific Symposium 1 Cutting edge of immuno-oncology |
Satellite Symposium 1  Future insight for the management of pancreatic and biliary tract cancers |
||
| 10:30-10:50 | Break | ||||
| 10:50-11:30 | Plenary Lecture 1 Implementing a comprehensive translational oncology platform in precision medicine: challenges, opportunities, and new directions Gordon B. MILLS (USA) |
||||
| 11:30-12:10 | Satellite Symposium 2 The current and future challenges: Good luck does not always repeat |
Satellite Symposium 3 The beginning of immunotherapy journey in breast cancer |
Satellite Symposium 4 Lenvatinib treatment in first line uHCC and subsequent treatments |
||
| 12:10-12:50 | Luncheon Symposium 1MSI- H (High microsatellite instability) : Predictive biomarkers in the era of precision medicine
| Luncheon Symposium 2Treatment paradigm shift in HCC: The combination revolution in IMbrave150
| |||
| 12:50-13:20 | Break | ||||
| 13:20-14:20 |
Oncology Multi-Disciplinary Symposium
KOR Practical issues of using insurance-covered immune checkpoint inhibitor in Korea |
Scientific Symposium 2 GU cancers |
|||
| 14:20-14:40 | Break | ||||
| 14:40-16:00 | Scientific Symposium 3 The evolving landscape of systemic treatment of NSCLC |
KOSRO/KSMO JS Role of local radiotherapy in the metastatic setting |
Satellite Symposium 5 Importance of bone health management in palliative setting |
||
Satellite Symposium 6 Changing lives with breakthrough cancer pain management |
|||||
| 16:00-16:20 | Break | ||||
| 16:20-17:40 | Scientific Symposium 4 Functional genomics |
Scientific Symposium 5 Progress in precision medicine |
Satellite Symposium 7 (16:20-17:00)  What is being considered for continuum of care in metastatic colorectal cancer? |
||
| 17:40-18:40 | Plenary Lecture 2 Functional genomics approaches to identify targetable dependencies in cancer cells Mathew J. GARNETT (UK) |
||||
| Time | A | B | C | D | |
|---|---|---|---|---|---|
| 08:00-09:00 | Scientific Symposium 6 CRC |
Scientific Symposium 7 Breast cancer |
Satellite Symposium 8 (08:00-08:40)  Broaden horizon of new PD-L1 inhibitor, Avelumab |
Poster & Exhibition |
|
| 09:00-10:30 | ASCO breakthrough Session Bench to bedside research in oncology |
Special Symposium 1 Opening a new chapter in clinical research of Korea BioPharm |
Satellite Symposium 9 (09:00-09:40)  New perspectives for treatment naïve patients with EGFR+ NSCLC |
||
| 10:30-10:50 | Break | ||||
| 10:50-11:30 | Plenary Lecture 3 Therapeutic targeting of the TAM receptor family in cancer Amato Giaccia (UK) |
Satellite Symposium 10 Continuing advances in metastatic breast cancer: How to make optimal treatment decision for metastatic breast cancer patients |
Satellite Symposium 11 Treatment options for patients with ALK+ NSCLC: How is the paradigm changing? |
||
| 11:30-12:10 | Noe Kyeong Kim Memorial Award & Lecture Clinical investigation for the management of advanced gastrointestinal stromal tumor (GIST) Yoon-Koo KANG (Korea) |
Satellite Symposium 12 Ever forward with cancer immunotherapy : The progress so far and new frontiers |
Satellite Symposium 13 From concept to practice - new era of precision medicine |
||
| 12:10-12:50 | Luncheon Symposium 3 Treatment landscape for HR+/HER2- aBC: focusing on CDK4/6 pathway
| Luncheon Symposium 4 Cutting-edge front-line treatment for advanced non-small cell lung cancer
| |||
| 12:50-13:20 | Break | ||||
| 13:20-14:20 | KCSG/KSMO JS Expanding the field of clinical trials to fulfill unmet clinical needs |
KSSO/KSMO JS Evolving role of surgery in a multidisciplinary approach |
Multidisciplinary Oncology Team Education Session 1
KOR
Understanding new paradigms of oncology clinical research & practice |
FACO Session 1 Update of FACO clinical trials |
|
| 14:20-14:40 | Break | ||||
| 14:40-16:00 | JSMO/KSMO JS Clinical genomics: Challenges and opportunities |
KSP/KSMO JS Updated cancer diagnosis platform: Present and future |
Multidisciplinary Oncology Team Education Session 2
KOR
Precision medicine in real-world |
FACO Session 2 Advance of immuno-oncologic strategies for Asian cancer patients |
|
| 16:00-16:20 | Break | ||||
| 16:20-17:40 | Scientific Symposium 8 GC/HBP cancers |
Scientific Symposium 9 Discovery of novel therapeutic targets |
Multidisciplinary Oncology Team Education Session 3
KOR
Multidisciplinary approaches in immuno-oncology incorporated into clinical practice |
Satellite Symposium 14 (16:20-17:00)   Building confidence in Biosimilars: From data to patient |
|
| 17:40-18:00 | Closing Ceremony | ||||
